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 CURRENTOPINION The emerging face of the HIV epidemic in the
Middle East and North Africa
Ghina R. Mumtaza, Gabriele Riednerb, and Laith J. Abu-Raddada,c,d
Purpose of review
A volume of quality HIV data has materialized recently in the Middle East and North Africa (MENA). This
review provides a thematic narrative of the patterns of HIV infection transmission in this region in light of
these data.
Recent findings
Tens of integrated bio-behavioral surveillance surveys among hard-to-reach key populations at higher risk
have been conducted in MENA in the recent years. Many of the studies reported appreciable and growing
HIV prevalence. A few studies found alarming prevalence of as much as 87.2% HIV prevalence among
people who inject drugs in Tripoli, Libya. The discovery of these hitherto hidden epidemics was unsettling
to some authorities after years in which the importance of a focus on HIV prevention among key
populations was not recognized.
Summary
The new data from MENA indicate growing HIV epidemics among key populations across the region.
There is heterogeneity, however, as to which key populations are affected and in what proportions in
different countries. In a few countries, HIV appears to affect only one key population and often there is
substantial geographical heterogeneity in HIV transmission. Data are indicative of a growing HIV disease
burden in this part of the globe, in contrast with the declining epidemics in most other regions.
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INTRODUCTION
Our knowledge of the HIV epidemic in the Middle
East and North Africa (MENA) has progressed
rapidly, with most of the evidence and quality
studies being conducted in the last few years [1].
The progress is a consequence of a concerted effort
involving national programs, international organ-
izations and donors, and academia to address the
dearth of HIV data [2]. Perhaps, the most significant
achievement has been the strengthening of sur-
veillance research in multiple countries. Tens
of integrated bio-behavioral surveillance surveys
(IBBSS) have been conducted using state-of-the-art
sampling methodologies for hard-to-reach key
populations at higher risk [2,3
&
]. There are still large
gaps in our understanding of HIV dynamics in
MENA; the availability of data varies extensively
from one country to another [1]. We review here
the main themes of our current understanding of
HIV epidemiology in MENA, in light of a volume of
data that have become available since 2010. We also
discuss key aspects that challenge a satisfactory
understanding of the epidemic in MENA.
This review covers the 23 countries that are part
of theMENA definitions of the three United Nations
organizations leading most HIV/AIDS efforts in the
region: the Joint United Nations Programme on
HIV/AIDS (UNAIDS), the Eastern Mediterranean
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(WHO/EMRO), and the World Bank. These
countries share historical, sociocultural, linguistic,
and religious characteristics; and are usually
included together as part of HIV/AIDS programming
for the region (Fig. 1).
HIV EPIDEMICS IN MIDDLE EAST AND
NORTH AFRICA: WHAT WE KNOW
Few themes define the emerging face of HIV epi-
demiology in MENA as discussed below.
A low HIV prevalence region
Several decades after the first cases of HIV infection
were reported in the region, MENA continues to be
characterized by a low HIV prevalence in the popu-
lation, at less than 0.2% in most countries [4–6].
This trend is consistent in both old and new data
including thousands of point-prevalence surveys
that have accumulated over the years from different
sources including individual studies, sentinel sur-
veillance, and HIV-testing databases of different
population groups [4]. Djibouti and part of Somalia
are exceptions to this trend, where HIV prevalence
among pregnant women has exceeded 1%, but this
appears to reflect the larger epidemics in commer-
cial heterosexual sex networks in these countries
compared with other countries of the region [4,7].
A trend of emerging HIV epidemics in key
populations at risk
The most distinctive feature of the epidemic in
MENA that manifested itself in the new data is
the rising HIV epidemics among key populations
including people who inject drugs (PWID), men
who have sex with men (MSM), and to a lesser
extent female sex workers (FSWs) [8
&
,9
&
,10]. The
majority of the epidemics appears to be relatively
recent with emergence within the last decade. Most
epidemics appear to be growing with a trend of
increasing HIV prevalence in multiple countries.
Table 1 displays HIV prevalence among key popu-
lations per the most recent available IBBSS studies;
KEY POINTS
 There are emerging, and sometimes rapidly growing,
HIV epidemics among the key populations at higher
risk in multiple countries in the MENA.
 Different countries are affected by the HIV epidemic in
different key populations, and in some countries only
one key population is affected.
 There is often within-country geographic heterogeneity
in HIV transmission among the different key
populations, and HIV prevalence can vary substantially
from one locality to another.
 Main challenges to a better understanding of HIV
epidemiology in the MENA include identifying
hidden HIV epidemics among the key populations,
a poor estimation of HIV disease burden, and
reconciling sometimes contradictory data from
different sources.
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FIGURE 1. Map of the MENA region including the countries that are covered in this review. MENA, Middle East and North
Africa. Reproduced with permission from [2].
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and Table 2 describes the status of the epidemic in
these populations based on all available data includ-
ing both recent and old data.
There are emerging concentrated HIV epidemics
among PWID in several MENA countries including
Afghanistan, Egypt, Morocco, and Pakistan [9
&
]. HIV
prevalence among PWID has increased steadily in
the repeated rounds of surveillance in Pakistan from
10.8% in 2005 to 37.8% in 2011–2012 [11–14,15
&
],
and in Egypt from 0.6% in 2006 to 6.7% in 2010
[16–18]. Iran is the only countrywhere the epidemic
among PWID has saturated nationally and is now
established at concentrated levels of about 15%
[9
&
,19–21]. In the first IBBSS conducted in Libya
in 2010–2011, Tripoli had the highest reported
HIV prevalence among PWID in MENA at 87.2%
[22
&
]. Although the epidemic among PWID in Libya
has been documented only recently and may have
saturated at a high level, it was suspected for several
years based onHIV testing and case notification data
[4,7,9
&
]. The epidemic also appears to be older than
most other epidemics in MENA, with an emergence
date probably in the late 1990s [4,7,22
&
].
In a few countries in MENA with insufficient
surveillance data such as Bahrain and Saudi Arabia,
the growing contribution of injecting drug use to
the total notified cases is indicative of appreciable
HIV transmission among PWID [9
&
]. Very limited
HIV transmission appears to occur among PWID in
some countries including Jordan, Lebanon, Pales-
tine, and Syria based on surveillance and case noti-
fication data (Tables 1 and 2) [9
&
].
A similar pattern of emerging HIV epidemics is
observed among MSM [8
&
]. After years of limited
Table 1. HIV prevalence among the key populations at higher risk in the countries of the Middle East and North Africa. These
data were compiled based on the results of tens of integrated bio-behavioral surveillance surveys in the period of 2010–2012.
The table includes also few earlier measurements relevant for the narrative of this review
PWID MSM FSWs
Year % Year % Year %
Afghanistan 2012 0.3–13.3 2012 0.4 2012 0.0–0.9
Algeria – – – – – –
Bahrain – – – – – –
Djibouti – – – – 2009 15.4
Egypt 2010 6.5–6.8 2010 0.0–6.9 2010 0.0
Iran 2011 15.2 – – 2010 4.5
Iraq – – – – – –
Jordan 2009 0.0 2009 0.2 2009 0.0
Kuwait – – – – – –
Lebanon 2007 0.0 2007 3.6 2007 0.0
2011 0.7
Libya 2011 87.2 2011 3.0 2011 16.0
Morocco 2011 0.4–25.1 2011 2.8–5.6 2011 0.0–5.1
Oman – – – – – –
Pakistan 2012 3.3–52.5 2012 0.0–5.9a 2012 0.0–1.9
0.0–14.9b
Palestine 2010 0.0 – – – –
Qatar – – – – – –
Saudi Arabia – – – – – –
Somalia – – – – 2007 5.3
Sudan – – 2011 0.0–6.3 2011 0.0–7.7
Syria – – – – – –
Tunisia 2011 0–2.7 2011 0.0–16.0 2011 0.0–1.2
U.A.E.c – – – – – –
Yemen – – 2010 5.9 2010 0.0
Note: A range indicates HIV prevalence in multiple cities. FSWs, female sex workers; PWID, people who inject drugs.
aMale sex workers.
bTransgender people.
cUnited Arab Emirates.
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transmission, HIV prevalence among MSM showed
a remarkable increase around 2003 (Fig. 2).
Although HIV prevalence remains at rather low to
intermediate levels (generally below 10%), emerg-
ing concentrated epidemics among MSM have been
recently documented in several countries including
Egypt, Morocco, Pakistan, Sudan, Tunisia, and
Yemen (Tables 1 and 2) [8
&
]. HIV prevalence among
transgender people in Pakistan increased steadily
from 0.8 to 7.2% between 2005 and 2011–2012
[11–14,15
&
]. Similarly in Tunisia, HIV prevalence
among MSM increased from 4.9% in 2009 to
13.0% in 2011 [23,24]. Case notification reports also
indicate that HIV transmission among MSM is
present and that its relative contribution is increas-
ing in several countries such as Egypt, Jordan,
Lebanon, Oman, and Syria (Fig. 3).
Overall, considerable HIV prevalence has not
been documented among FSWs inMENA. The high-
est prevalence is reported in Djibouti at up to
20.0% in facility-based surveys in 2007–2009 [24].
Concentrated HIV epidemics among FSWs are
found in at least parts of Libya, Morocco, Somalia,
and Sudan (Tables 1 and 2). In Eastern Sudan, 5.0
and 7.8% of FSWs in two cities were found to be
infected with HIV [25
&
]; and in Tripoli, Libya,
15.7% were infected [26]. The region, however,
does not appear to have witnessed rapidly grow-
ing HIV epidemics among FSWs, and in several
countries, the epidemic among FSWs appears to be
stable at relatively low prevalence. In Morocco,
and despite a concentrated epidemic in Agadir
[27], the epidemic seems to be hovering around
a national prevalence of only about 2% for over a
decade [28].
Despite the overall relatively low HIV preva-
lence among FSWs, commercial heterosexual sex
networks appear to be a main driver of HIV inci-
dence in at least few countries, probably because of
the larger size of these networks compared with
PWID and MSM networks. In Morocco, as con-
firmed by a recent HIV Modes of Transmission
Table 2. Evidence of appreciable HIV transmission among the key populations at higher risk in the countries of the Middle
East and North Africa. These results are based on a triangulation of data from multiple lines of evidence including both recent
and older data
PWID MSM FSWs
Afghanistan Yes No No
Algeria Unknown Unknown Unknown
Bahrain Possibly Unknown Unknown
Djibouti Unknown Unknown Yes
Egypt Yes Yes No
Iran Yes Possibly Possibly
Iraq Unknown Unknown Unknown
Jordan No Possibly No
Kuwait Unknown Unknown Unknown
Lebanon No Yes No
Libya Yes Possibly Yes
Morocco Yes Yes Yes
Oman Possibly Possibly Unknown
OPT No Unknown Unknown
Pakistan Yes Yes Possibly
Qatar Unknown Unknown Unknown
Saudi Arabia Possibly Unknown Unknown
Somalia Unknown Unknown Yes
Sudan Unknown Yes Yes
Syria No Possibly Unknown
Tunisia Possibly Yes Possibly
U.A.E.a Unknown Unknown Unknown
Yemen Unknown Yes No
Yes: There is evidence of appreciable HIV transmission based on different types of available data, No: There is no evidence of appreciable HIV transmission
based on different types of available data, Possibly: There is some evidence of HIV transmission based on different types of available data, but the evidence is not
conclusive, Unknown: The data are too limited to know the potential status of HIV transmission. FSWs, female sex workers; PWID, people who inject drugs.
aUnited Arab Emirates.
Epidemiology: concentrated epidemics
186 www.co-hivandaids.com Volume 9  Number 2  March 2014
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
(MoT) modeling analysis, commercial heterosexual
sex networks contributed about half of HIV inci-
dence despite a rather low HIV prevalence among
FSWs of about 2% [29
&
].
For several countries, it is not clear howmuch of
the observed HIV prevalence among FSWs truly
reflects acquisition through heterosexual sex versus
acquisition through injecting drug use. This situ-
ation is specifically the case in countries with large
epidemics among PWID. In Iran, about 15% of FSWs
reported injecting drugs [30], and these were over
three timesmore likely to be HIV infected compared
with FSWs who never injected drugs [30]. It is plaus-
ible that most of HIV infections among FSWs in Iran
could be due to drug injection rather than sexual
transmission.
For a considerable fraction of MENA countries,
recent data affirm very low HIV prevalence among
FSWs as consistently observed in Afghanistan, Egypt,
Jordan, Lebanon, Pakistan, Tunisia, and Yemen
(Tables 1 and 2).
Heterogeneity in key populations at risk
affected
There is large heterogeneity across countries as to
which key populations are proportionally affected
by the epidemic, as opposed to others (Table 2).
Most HIV transmissions in Iran and Pakistan appear
to be driven by the large HIV epidemics among
PWID in these countries [9
&
,31]. This situation is,
however, not the case in Lebanon and Tunisia where
HIV transmission among MSM seems to be domi-
nant [24]. Similarly, substantial HIV prevalence is
found among FSWs in Djibouti and probably Soma-
lia, but generally this is not the case in other
MENA countries.
There seems to be some instances of regionali-
zation of the key populations affected, with neigh-
boring countries being affected by similar epidemic
dynamics. Large HIV epidemics are found among
PWID in the three neighboring countries of
Iran, Pakistan, and Afghanistan [9
&
]. Similarities in
viral subtypes between these countries suggest
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FIGURE 2. Trend of HIV prevalence among men who have sex with men in the Middle East and North Africa, 1990–2012.
The figure is adapted from [8&] with permission, but updated with the most recent rounds of surveillance (2010–2012) and
including city-level prevalence data.
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circulation of the virus across national borders fol-
lowing the drug trade routes in this part of MENA
[10,32,33]. The epidemic that started in Iran may
have moved from there to Pakistan and Afghani-
stan. It is believed that HIV might have been intro-
duced to PWID in Afghanistan through the return of
Afghani refugees from Iran following the fall of
Taliban [10,32].
In addition to the heterogeneity on which key
populations are proportionally affected, it seems
that epidemic transmission in a number of countries
is largely driven by only one key population, at least
so far. The epidemic in Lebanon appears to be largely
confined to MSM; and in Afghanistan and Iran to
PWID (Table 2). This situation might be due to the
rather recent nature of the epidemics in these
countries where HIV infection has not yet been
bridged and percolated among other key popula-
tions.
In other countries, however, the epidemic has
already affectedmore than one key population, with
the epidemic usually starting in one key population
and thenmoving to other ones through overlapping
risk behavior. This situation appears to be the case of
Pakistan and Egypt. In Pakistan, the HIV epidemic
amongmale sexworkers and transgender people has
closely followed the emergence of the epidemic
among PWID [9
&
,11–14,15
&
]. Behavioral data con-
firmed the overlap of risk behavior with a sizable
proportion of male sex workers and transgender
people being PWID themselves or having PWID
sexual partners [9
&
,11–14,15
&
]. Molecular epidemi-
ology evidence has also linked the HIV virus subtype
among PWID in Pakistan to that among MSM
suggesting that the epidemic among MSM could
have been sparked by the epidemic among PWID
[10]. A similar pattern, but in the opposite direction,
may have occurred in Egypt, where the nascent HIV
epidemic among PWID seems to have been bridged
from the epidemic that occurred earlier amongMSM
[9
&
]. This conjecture is supported by behavioral data
that indicate considerable overlap of risk behavior
between MSM and PWID in Egypt [16–18].
Geographic clustering of HIV epidemics
Recent data suggest within-country geographic
heterogeneity in HIV transmission. In some cases,
a key population in only one locality appears to
be affected by the epidemic, and in other cases,
different geographic regions are affected by different
key populations epidemics. Morocco provides an
example where the epidemic among PWID appears
to be localized in Northern Morocco, and specially
in Nador with a high HIV prevalence of 25.1%
[28,34]. Evidence to date suggests limited HIV infec-
tion burden among PWID in the rest of the country.
Nonetheless, HIV sexual transmission is focused in
the South of the country, specially in Agadir where
concentrated HIV epidemics among FSWs andMSM
0
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FIGURE 3. Proportion of total notified HIV cases (2011) that are the result of heterosexual practices, men who have sex with
men, or injecting drug use exposures in the countries of the Middle East and North Africa with available data [24]. Original
figure, data from [24].
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are found. HIV prevalence in Agadir was found to be
5.1% among FSWs [27] and 5.6% among MSM
[35,36].
Sudan provides another example of geographic
disparities inHIVprevalence among FSWs. In a large-
scale national survey conducted in 2011, concen-
trated HIV epidemics among FSWs were observed
in Eastern Sudan (HIV prevalence 5.0–7.7%),
whereas limited infection burden was detected in
the other zones (HIV prevalence 0.0–1.5%) [25
&
].
Heterogeneity in transmission is observed in other
MENA countries, but may not always reflect true
heterogeneity as much as incomplete national HIV
surveillance.
The spatial heterogeneity in HIV transmission
may be explained by the recent nature of the
epidemics in MENA, and the fact that many are
growing. HIV infection may have affected one key
population at a specific location, but may not have
yet reached the same key population in other parts
of the country.
HIV EPIDEMICS IN MIDDLE EAST AND
NORTH AFRICA: CHALLENGES TO OUR
UNDERSTANDING
We discuss below key aspects that challenge a
satisfactory understanding of the epidemic in this
region.
Hidden HIV epidemics
Identifying hidden HIV epidemics among key popu-
lations remains a long-standing challenge for HIV
research and programming inMENA.On the basis of
a recent assessment, only four out of 23 MENA
countries qualified as having functioning surveil-
lance systems capable of tracking emerging HIV
epidemics [3
&
]. Previous experience in the region
has shown that there are hidden HIV epidemics that
are discovered only after IBBSS studies are con-
ducted; sometimes too late as HIV prevalence would
have reached high and even alarming levels. The
first IBBSS in Libya was conducted in 2010–2011,
unveiling a major epidemic among PWID with a
prevalence of 87.2%, one of the highest globally
[22
&
]. The prevalence of 25.1% among PWID in
Nador, Morocco was also discovered for the first
time in 2008 in an IBBSS [28,34,37]. Similarly, the
first IBBSS studies conducted among MSM in Egypt
and Tunisia identified already concentrated epidem-
ics with a prevalence exceeding 5% [16–18,23,24].
These discoveries of hitherto hidden epidemics were
unsettling to some authorities after years in which
the importance of a focus onHIV prevention among
key populations was not recognized.
In several MENA countries including Algeria,
Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia,
Syria, and United Arab Emirates, data are scarce. The
status of the epidemic remains largely unknown,
not precluding the possibility of hidden epidemics.
This situation is especially the case wherein case
notifications suggest increasing contribution of a
specific mode of exposure among recently notified
HIV cases such as among MSM in Oman and Syria
and PWID in Saudi Arabia (Fig. 3).
Poor estimation of HIV disease burden
MENA suffers overall from poor estimation of its
HIV disease burden. Estimates in the region are
typically produced by national authorities work-
ing with the Joint United Nations Programme on
HIV/AIDS (UNAIDS), through application of estab-
lished mathematical models used in other regions.
However, the nature and volume of data in MENA
are not yet conducive for a representative appli-
cation of these models. The models have often been
parameterized by poor data input leading in
occasions to questionable estimates. Even when
the estimates seemed plausible, they usually came
with wide confidence intervals.
The quality of disease burden estimates can be
improved by further primary data collection among
key populations including IBBSS and risk group
size estimations. Custom-designed mathematical
models may be appropriate for some countries
given the nature of available data. Although
countries overall have inadequate data to power
concrete estimates by UNAIDS models, there are
sources of data available that have not been com-
monly used, but could be utilized within the con-
text of custom-designed models. Examples of these
include HIV-testing databases and case notifica-
tions.
Apparently contradictory data
The recent progress in HIV research in MENA has
entailed a wider availability of different types of data
sources using different lines of evidence and study
methodologies. The wider data availability have
confronted HIV stakeholders with a new challenge:
reconciling apparently contradictory data. For
example, in Tunisia, case notifications attribute
87% of HIV cases in 2011 to heterosexual sex with
small contribution due to MSM (Fig. 3). The IBBSS
studies, however, identified limited HIV prevalence
among FSWs (0.0–1.2%), but high prevalence of up
to 16.0% among MSM (Table 1) [24]. It is not clear
why the large HIV prevalence among MSM is not
expressed as a larger share of case notifications. It is
HIV epidemics in the Middle East and North Africa Mumtaz et al.
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also not clear how these heterosexual notified
cases have been acquired if there does not appear
to be a significant core of HIV transmission among
commercial heterosexual sex networks. This appa-
rent contradiction was even compounded with
the findings of the MoT modeling study in Tunisia,
which linked the bulk of HIV incidence to MSM
[24].
Similarly, case notification data suggest the pres-
ence of considerable HIV transmission among MSM
in Jordan and Lebanon (Fig. 3); a fact supported by
anecdotal evidence conveyed by HIV stakeholders
in these countries. Yet, in both countries, recent
IBBSS studies reported limited HIV prevalence
among MSM with most cases in the surveys being
HIV-infected seeds in the respondent-driven sampl-
ing (Table 1) [24,38,39].
Some of these contradictions may be explained
by the limitations in available data. Some forms of
exposure may not be reported accurately in case
notifications, such as those related to MSM. Some
of the IBBSS studies may have sampled only a
‘visible’ part of the key population, and may not
have reached deeply into key population networks.
Their findings, therefore, may not be representative
of the wider population of key populations.
Although limitations in available data may
explain, in part, some of these contradictions, we
believe, based on the totality of available evidence,
that much of these contradictions are paradoxes
that reflect our incomplete understanding of HIV
dynamics in some of the MENA countries. For
example, size estimations of key populations are
far frombeing adequate, and their scalemay explain
some of these contradictions. There is also a flow of
HIV infections through national borders through
in-migration and out-migration, and understand-
ing this flowmayhelp explain some contradictions.
With further data accumulating over the coming
years, these apparently contradictory data may be
seen as merely accurate ‘still images’ of a more
subtle and complex dynamics of infection trans-
mission.
CONCLUSION
A volume of data on HIV infection in MENA has
become available in the last few years, although for a
number of countries data remain limited. The key
features of the epidemic gleaned from these novel
data indicate growing, and in occasions, rapidly
growing, HIV epidemics among key populations
across the region. These findings are indicative of
a rising HIV disease burden in this part of the globe,
in contrast with the declining HIV epidemics in
most other regions.
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